• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人铜转运体:机制、在人类疾病中的作用和治疗潜力。

Human copper transporters: mechanism, role in human diseases and therapeutic potential.

机构信息

Department of Physiology, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

Future Med Chem. 2009 Sep;1(6):1125-42. doi: 10.4155/fmc.09.84.

DOI:10.4155/fmc.09.84
PMID:20454597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2863355/
Abstract

Normal copper homeostasis is essential for human growth and development. Copper deficiency, caused by genetic mutations, inadequate diet or surgical interventions, may lead to cardiac hypertrophy, poor neuronal myelination, blood vessel abnormalities and impaired immune response. Copper overload is associated with morphological and metabolic changes in tissues and, if untreated, eventual death. Recent reports also indicate that changes in the expression of copper transporters alter the sensitivity of cancer cells to major chemotherapeutic drugs, such as cisplatin, although the mechanism behind this important phenomenon remains unclear. This review summarizes current information on the molecular characteristics of copper transporters CTR1, CTR2, ATP7A and ATP7B, their roles in mammalian copper homeostasis and the physiological consequences of their inactivation. The mechanisms through which copper transporters may influence cell sensitivity to cisplatin are discussed. Regulation of human copper homeostasis has significant therapeutic potential and requires the detailed understanding of copper transport mechanisms.

摘要

正常的铜稳态对人类的生长和发育至关重要。由于基因突变、饮食不足或手术干预等原因导致的铜缺乏,可能导致心脏肥大、神经元髓鞘形成不良、血管异常和免疫反应受损。铜过载与组织的形态和代谢变化有关,如果不加以治疗,最终会导致死亡。最近的报告还表明,铜转运蛋白表达的变化改变了癌细胞对顺铂等主要化疗药物的敏感性,尽管这一重要现象背后的机制尚不清楚。本综述总结了铜转运蛋白 CTR1、CTR2、ATP7A 和 ATP7B 的分子特征、它们在哺乳动物铜稳态中的作用以及它们失活的生理后果的最新信息。讨论了铜转运蛋白可能影响细胞对顺铂敏感性的机制。人类铜稳态的调节具有重要的治疗潜力,需要详细了解铜转运机制。

相似文献

1
Human copper transporters: mechanism, role in human diseases and therapeutic potential.人铜转运体:机制、在人类疾病中的作用和治疗潜力。
Future Med Chem. 2009 Sep;1(6):1125-42. doi: 10.4155/fmc.09.84.
2
The roles of copper transporters in cisplatin resistance.铜转运蛋白在顺铂耐药中的作用。
Cancer Metastasis Rev. 2007 Mar;26(1):71-83. doi: 10.1007/s10555-007-9045-3.
3
Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.铜转运体 ATP7B 介导的肿瘤对顺铂耐药的机制。
Biochem Cell Biol. 2011 Apr;89(2):138-47. doi: 10.1139/o10-150.
4
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.与人类卵巢癌细胞顺铂耐药相关的铜离子外流转运蛋白ATP7A和ATP7B的定位改变。
BMC Cancer. 2008 Jun 19;8:175. doi: 10.1186/1471-2407-8-175.
5
Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.铜转运蛋白2调节细胞内铜含量和顺铂敏感性。
Metallomics. 2014 Mar;6(3):654-61. doi: 10.1039/c3mt00331k. Epub 2014 Feb 13.
6
Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.人铜转运ATP 酶 ATP7A 和 ATP7B 对铂类抗癌药物的转运。
Angew Chem Int Ed Engl. 2014 Jan 27;53(5):1297-301. doi: 10.1002/anie.201307718. Epub 2013 Dec 27.
7
Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.铜转运ATP酶ATP7B与顺铂的功能相互作用及ATP7B在细胞对该药物耐药性中的作用。
J Biol Chem. 2009 Mar 20;284(12):7793-802. doi: 10.1074/jbc.M805145200. Epub 2009 Jan 13.
8
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human solid carcinomas.铜转运P型三磷酸腺苷酶(ATP7B)在人类实体癌中作为化疗耐药标志物的表达。
Ann Thorac Cardiovasc Surg. 2005 Jun;11(3):143-5.
9
Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.铜外流转运蛋白(ATP7B)有助于人类口腔鳞状细胞系获得顺铂耐药性。
Oncol Rep. 2007 Oct;18(4):987-91.
10
Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.Sec61β 通过调节铜转运 ATP 酶 ATP7A 来控制对含铂化疗药物的敏感性。
Mol Pharmacol. 2012 Sep;82(3):510-20. doi: 10.1124/mol.112.079822. Epub 2012 Jun 18.

引用本文的文献

1
Copper homeostasis and cuproptosis in Alzheimer's disease (Review).阿尔茨海默病中的铜稳态与铜死亡(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5613. Epub 2025 Aug 24.
2
Zinc-Dependent Modulation of Dopamine Release and Uptake Is Altered in Parkinson's Disease Model Zebrafish.帕金森病模型斑马鱼中锌依赖的多巴胺释放和摄取调节发生改变。
ACS Chem Neurosci. 2025 May 21;16(10):1872-1882. doi: 10.1021/acschemneuro.4c00864. Epub 2025 Apr 30.
3
Computational studies on the functional and structural impact of pathogenic mutations in enzymes.酶中致病突变对功能和结构影响的计算研究。
Protein Sci. 2025 Apr;34(4):e70081. doi: 10.1002/pro.70081.
4
Role of copper homeostasis and cuproptosis in heart failure pathogenesis: implications for therapeutic strategies.铜稳态和铜死亡在心力衰竭发病机制中的作用:对治疗策略的启示。
Front Pharmacol. 2025 Jan 9;15:1527901. doi: 10.3389/fphar.2024.1527901. eCollection 2024.
5
Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer.用纳米材料靶向铜死亡:提高结直肠癌免疫治疗疗效的新途径。
Front Pharmacol. 2024 Dec 3;15:1451067. doi: 10.3389/fphar.2024.1451067. eCollection 2024.
6
Copper homeostasis and cuproptosis in central nervous system diseases.中枢神经系统疾病中的铜稳态和铜死亡。
Cell Death Dis. 2024 Nov 21;15(11):850. doi: 10.1038/s41419-024-07206-3.
7
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy.铜稳态与肿瘤免疫中的铜诱导细胞死亡:对癌症免疫治疗策略的启示
Biomark Res. 2024 Oct 31;12(1):130. doi: 10.1186/s40364-024-00677-8.
8
Evaluation the Effects of Copper Nanoparticles Dietary Supplementation on Growth Performance, Carcass Characteristics, and Serum Antioxidant Status in Broilers.评估日粮添加纳米铜对肉鸡生长性能、胴体特性和血清抗氧化状态的影响。
Biol Trace Elem Res. 2025 Jun;203(6):3287-3294. doi: 10.1007/s12011-024-04383-2. Epub 2024 Oct 1.
9
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer.lncRNAs 作为铜死亡介导的癌症的预后标志物和治疗靶点。
Clin Exp Med. 2024 Sep 26;24(1):226. doi: 10.1007/s10238-024-01491-0.
10
Is Copper Still Safe for Us? What Do We Know and What Are the Latest Literature Statements?铜对我们来说仍然安全吗?我们了解些什么,最新的文献观点又是什么?
Curr Issues Mol Biol. 2024 Aug 2;46(8):8441-8463. doi: 10.3390/cimb46080498.

本文引用的文献

1
Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.铜转运蛋白2调节顺铂和卡铂的细胞蓄积及细胞毒性。
Clin Cancer Res. 2009 Jul 1;15(13):4312-21. doi: 10.1158/1078-0432.CCR-09-0311. Epub 2009 Jun 9.
2
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.卵巢癌中ATP7B的治疗靶点
Clin Cancer Res. 2009 Jun 1;15(11):3770-80. doi: 10.1158/1078-0432.CCR-08-2306. Epub 2009 May 26.
3
Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage.细胞特异性转运提示肾ATP7B在细胞内铜储存中具有新作用。
Traffic. 2009 Jun;10(6):767-79. doi: 10.1111/j.1600-0854.2009.00901.x. Epub 2009 Feb 18.
4
Copper transport into the secretory pathway is regulated by oxygen in macrophages.巨噬细胞中铜向分泌途径的转运受氧气调节。
J Cell Sci. 2009 May 1;122(Pt 9):1315-21. doi: 10.1242/jcs.043216. Epub 2009 Apr 7.
5
Three-dimensional structure of the human copper transporter hCTR1.人类铜转运蛋白hCTR1的三维结构。
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4237-42. doi: 10.1073/pnas.0810286106. Epub 2009 Feb 24.
6
The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.铜转运蛋白ATP7B的可溶性金属结合结构域可结合顺铂并使其解毒。
Biochem J. 2009 Apr 1;419(1):51-6, 3 p following 56. doi: 10.1042/BJ20081359.
7
Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.铜转运ATP酶ATP7B与顺铂的功能相互作用及ATP7B在细胞对该药物耐药性中的作用。
J Biol Chem. 2009 Mar 20;284(12):7793-802. doi: 10.1074/jbc.M805145200. Epub 2009 Jan 13.
8
Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis.肝脏中Ctr1的缺失揭示了其在铜摄取及铜稳态补偿机制中的功能。
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G356-64. doi: 10.1152/ajpgi.90632.2008. Epub 2008 Dec 18.
9
Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.铜蓝蛋白的显性突变体损害了无铜蓝蛋白血症中的铜装载机制。
J Biol Chem. 2009 Feb 13;284(7):4545-54. doi: 10.1074/jbc.M805688200. Epub 2008 Dec 18.
10
Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up.胆胰转流术的临床结果及营养后果:三年随访
Ann Nutr Metab. 2008;53(3-4):234-9. doi: 10.1159/000185641. Epub 2008 Dec 16.